Back to search

BSR guidelines for prescribing TNF-α blockers in adults with ankylosing spondylitis. Report of a working party of the British Society for Rheumatology

Data up to Jan 2025

Published2005
Citations94
References50

Total Citations Per Year

Abstract

References (50)

Evaluation of Diagnostic Criteria for Ankylosing Spondylitis

1984 • 5,334 citations

A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index.

1994 • 3,015 citations

ANKYLOSING SPONDYLITIS AND HL-A 27

1973 • 1,801 citations

Treatment of active ankylosing spondylitis with infliximab: a randomised controlled multicentre trial

2002 • 1,272 citations

Recombinant human tumor necrosis factor receptor (etanercept) for treating ankylosing spondylitis: A randomized, controlled trial

2003 • 743 citations

Treatment of Ankylosing Spondylitis by Inhibition of Tumor Necrosis Factor α

2002 • 679 citations

[Criteria of the classification of spondylarthropathies].

1990 • 577 citations

Development of the ASQoL: a quality of life instrument specific to ankylosing spondylitis

2002 • 546 citations

Six‐month results of a double‐blind, placebo‐controlled trial of etanercept treatment in patients with active ankylosing spondylitis

2003 • 455 citations

International ASAS consensus statement for the use of anti-tumour necrosis factor agents in patients with ankylosing spondylitis

2003 • 431 citations

Magnetic resonance imaging examinations of the spine in patients with ankylosing spondylitis, before and after successful therapy with infliximab: Evaluation of a new scoring system

2003 • 400 citations

Randomized double‐blind comparison of chimeric monoclonal antibody to tumor necrosis factor α (infliximab) versus placebo in active spondylarthropathy

2002 • 353 citations

Economic burden of rheumatoid arthritis: a systematic review

2000 • 345 citations

Update on the British Society for Rheumatology guidelines for prescribing TNF blockers in adults with rheumatoid arthritis (update of previous guidelines of April 2001)

2005 • 340 citations

Differential efficacy of tumor necrosis factor inhibition in the management of inflammatory eye disease and associated rheumatic disease

2001 • 333 citations

Disability and handicap in rheumatoid arthritis and ankylosing spondylitis--results from the German rheumatological database. German Collaborative Arthritis Centers.

2000 • 325 citations

Efficacy of etanercept in the treatment of the entheseal pathology in resistant spondylarthropathy: A clinical and magnetic resonance imaging study

2001 • 305 citations

Long‐term efficacy and safety of infliximab in the treatment of ankylosing spondylitis: An open, observational, extension study of a three‐month, randomized, placebo‐controlled trial

2003 • 271 citations

Mortality and causes of death in 398 patients admitted to hospital with ankylosing spondylitis.

1993 • 249 citations

Efficacy of celecoxib, a cyclooxygenase 2-specific inhibitor, in the treatment of ankylosing spondylitis: A six-week controlled study with comparison against placebo and against a conventional nonsteroidal antiinflammatory drug

2001 • 247 citations

Immunomodulatory effects of anti-tumor necrosis factor ? therapy on synovium in spondylarthropathy: Histologic findings in eight patients from an open-label pilot study

2001 • 187 citations

Infliximab in ankylosing spondylitis: a prospective observational inception cohort analysis of efficacy and safety.

2002 • 147 citations

Efficacy of infliximab in refractory ankylosing spondylitis: results of a six-month open-label study

2002 • 142 citations

Clinical and imaging correlates of response to treatment with infliximab in patients with ankylosing spondylitis.

2001 • 138 citations

Successful short term treatment of severe undifferentiated spondyloarthropathy with the anti-tumor necrosis factor-alpha monoclonal antibody infliximab.

2002 • 136 citations

Functional disability predicts total costs in patients with ankylosing spondylitis

2002 • 134 citations

Ankylosing spondylitis in rochester, minnesota, 1935–1989. Is the epidemiology changing?

1992 • 133 citations

Guideline for anti-TNF-α therapy in psoriatic arthritis

2005 • 130 citations

Increase in bone mineral density of patients with spondyloarthropathy treated with anti-tumour necrosis factor alpha

2003 • 127 citations

Repeated infusions of infliximab, a chimeric anti-TNFalpha monoclonal antibody, in patients with active spondyloarthropathy: one year follow up

2002 • 124 citations

Functional disability predicts total costs in patients with ankylosing spondylitis

2002 • 123 citations

Aetiology of Ankylosing Spondylitis

1949 • 119 citations

Work disability among people with ankylosing spondylitis

2001 • 113 citations

QUALITY OF LIFE IN PATIENTS WITH ANKYLOSING SPONDYLITIS

1998 • 107 citations

Down‐regulation of the nonspecific and antigen‐specific T cell cytokine response in ankylosing spondylitis during treatment with infliximab

2003 • 105 citations

How should clinicians manage osteoporosis in ankylosing spondylitis?

2002 • 91 citations

Employment perspectives of patients with ankylosing spondylitis

2002 • 83 citations

Total hip arthroplasty in ankylosing spondylitis: outcome in 340 patients.

2001 • 80 citations

Bone mass in ankylosing spondylitis.

1986 • 75 citations

Infliximab therapy in patients with ankylosing spondylitis: an open label 12 month study

2003 • 75 citations

Direct and indirect costs associated with the onset of seropositive rheumatoid arthritis. Western Consortium of Practicing Rheumatologists.

2000 • 74 citations

Canadian Rheumatology Association Consensus on the use of anti-tumor necrosis factor-alpha directed therapies in the treatment of spondyloarthritis.

2003 • 66 citations

Anti-tumour necrosis factor therapy for ankylosing spondylitis: international experience

2002 • 62 citations

GENES IN THE SPONDYLOARTHROPATHIES

1998 • 49 citations

Potential of tumor necrosis factor neutralization strategies in rheumatologic disorders other than rheumatoid arthritis

2003 • 41 citations

Distribution of HLA B27 and ankylosing spondylitis in the Hungarian population.

1977 • 33 citations

Building consensus on nomenclature and disease classification for ankylosing spondylitis: results and discussion of a questionnaire prepared for the International Workshop on New Treatment Strategies in Ankylosing Spondylitis, Berlin, Germany, 18-19 January 2002

2002 • 32 citations

NSAIDs in ankylosing spondylitis.

2002 • 29 citations

Ankylosing spondylitis and HL-A

1975 • 11 citations

Health outcomes in ankylosing spondylitis : an evaluation of patient-based and anthropometric measures.

2000 • 6 citations

Cited By (0)

Loading...
BSR guidelines for prescribing TNF-α blockers in adults with ankylosing spondylitis.… (2005) – Lara D. Veeken | Metascience Observatory Explorer